Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Mar 19, 2010	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-10-061761.pdf 0001193125-10-061761.rtf 0001193125-10-061761.xls
Jan 18, 2012	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-12-014808.pdf 0001193125-12-014808.rtf 0001193125-12-014808.xls
Mar 19, 2010	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-10-061766.pdf 0001193125-10-061766.rtf 0001193125-10-061766.xls
Jan 18, 2012	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-12-014812.pdf 0001193125-12-014812.rtf 0001193125-12-014812.xls
Mar 19, 2010	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-10-061751.pdf 0001193125-10-061751.rtf 0001193125-10-061751.xls
Mar 19, 2010	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-10-061746.pdf 0001193125-10-061746.rtf 0001193125-10-061746.xls
Jan 18, 2012	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-12-014805.pdf 0001193125-12-014805.rtf 0001193125-12-014805.xls
Jan 18, 2012	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	View HTML 0001193125-12-014816.pdf 0001193125-12-014816.rtf 0001193125-12-014816.xls
Jan 18, 2012	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	View HTML 0001193125-12-014831.pdf 0001193125-12-014831.rtf 0001193125-12-014831.xls
Jan 18, 2012	S-8 POS	Post-effective amendment to an S-8 filing	Registration Statements	View HTML 0001193125-12-014832.pdf 0001193125-12-014832.rtf 0001193125-12-014832.xls

Data provided by Kaleidoscope.